186 related articles for article (PubMed ID: 31191832)
1. Celiac disease in Iranian irritable bowel syndrome patients; a systematic review and meta-analysis.
Azami M; Badfar G; Abangah G; Mahmoudi L
Gastroenterol Hepatol Bed Bench; 2019; 12(2):85-97. PubMed ID: 31191832
[TBL] [Abstract][Full Text] [Related]
2. Prevalence of celiac disease in Iranian patients with irritable bowel syndrome: a cross-sectional study.
Shayesteh AA; Hajiani E; Hashemi SJ; Masjedizadeh A; Latifi SM; Shayesteh M
J Dig Dis; 2014 Jan; 15(1):12-7. PubMed ID: 24320042
[TBL] [Abstract][Full Text] [Related]
3. Screening for Celiac Disease in Irritable Bowel Syndrome: An Updated Systematic Review and Meta-analysis.
Irvine AJ; Chey WD; Ford AC
Am J Gastroenterol; 2017 Jan; 112(1):65-76. PubMed ID: 27753436
[TBL] [Abstract][Full Text] [Related]
4. The seroprevalence of celiac disease in patients with symptoms of irritable bowel syndrome: A cross-sectional study in the north of Iran.
Joukar F; Yeganeh S; Shafaghi A; Mahjoub-Jalali MR; Hassanipour S; Santacroce L; Mavaddati S; Mansour-Ghanaei F
Hum Antibodies; 2022; 30(2):97-103. PubMed ID: 35342083
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of celiac disease and related antibodies in patients diagnosed with irritable bowel syndrome according to the Rome III criteria. A case-control study.
Sánchez-Vargas LA; Thomas-Dupont P; Torres-Aguilera M; Azamar-Jacome AA; Ramírez-Ceervanes KL; Aedo-Garcés MR; Meixueiro-Daza A; Roesch-Dietlen F; Grube-Pagola P; Vivanco-Cid H; Remes-Troche JM
Neurogastroenterol Motil; 2016 Jul; 28(7):994-1000. PubMed ID: 26914655
[TBL] [Abstract][Full Text] [Related]
6. Celiac disease prevalence in the patients with irritable bowel syndrome in the ilam province; a cross sectional study from Western iran.
Mahmoodi A; Jafarihaydarlo A; Yasemi M; Hemati K; Peyman H
J Clin Diagn Res; 2014 Dec; 8(12):GC01-3. PubMed ID: 25653962
[TBL] [Abstract][Full Text] [Related]
7. Undiagnosed Celiac Disease In Patients Presenting With Irritable Bowel Syndrome Symptoms.
Khayyat YM
J Ayub Med Coll Abbottabad; 2020; 32(1):18-23. PubMed ID: 32468748
[TBL] [Abstract][Full Text] [Related]
8. Clinical utility of serologic testing for celiac disease in ontario: an evidence-based analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2010; 10(21):1-111. PubMed ID: 23074399
[TBL] [Abstract][Full Text] [Related]
9. Coeliac disease in irritable bowel syndrome (Rome III) in Southeast Iran.
Bakhshipour A; Nezam SK; Zakeri Z; Gharibi R; Bahari A; Kaykhaei MA
Arab J Gastroenterol; 2012 Mar; 13(1):24-7. PubMed ID: 22560821
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and tolerability of alosetron for the treatment of irritable bowel syndrome in women and men: a meta-analysis of eight randomized, placebo-controlled, 12-week trials.
Rahimi R; Nikfar S; Abdollahi M
Clin Ther; 2008 May; 30(5):884-901. PubMed ID: 18555935
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of irritable bowel syndrome and its association with colorectal cancer: a systematic review and meta-analysis.
Wickramasinghe D; Kamburugamuwa S; Xavier C; Samarasekera N; Warusavitarne J
ANZ J Surg; 2023 Jun; 93(6):1480-1486. PubMed ID: 36757832
[TBL] [Abstract][Full Text] [Related]
12. Tegaserod for the treatment of irritable bowel syndrome and chronic constipation.
Evans BW; Clark WK; Moore DJ; Whorwell PJ
Cochrane Database Syst Rev; 2007 Oct; (4):CD003960. PubMed ID: 17943807
[TBL] [Abstract][Full Text] [Related]
13. Serological Screening for Celiac Disease in Adult Chinese Patients With Diarrhea Predominant Irritable Bowel Syndrome.
Wang H; Zhou G; Luo L; Crusius JBA; Yuan A; Kou J; Yang G; Wang M; Wu J; von Blomberg BME; Morré SA; Peña AS; Xia B
Medicine (Baltimore); 2015 Oct; 94(42):e1779. PubMed ID: 26496305
[TBL] [Abstract][Full Text] [Related]
14. The prevalence of celiac disease in patients with irritable bowel syndrome and its subtypes.
Domżał-Magrowska D; Kowalski MK; Szcześniak P; Bulska M; Orszulak-Michalak D; Małecka-Panas E
Prz Gastroenterol; 2016; 11(4):276-281. PubMed ID: 28053683
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of irritable bowel syndrome-type symptoms in patients with celiac disease: a meta-analysis.
Sainsbury A; Sanders DS; Ford AC
Clin Gastroenterol Hepatol; 2013 Apr; 11(4):359-65.e1. PubMed ID: 23246645
[TBL] [Abstract][Full Text] [Related]
16. The Prevalence of Anti-Zein Antibodies: A Comparative Study between Celiac Disease and Irritable Bowel Syndrome.
Sánchez-Vargas LA; Hernández-Flores KG; Cabrera-Jorge FJ; Remes-Troche JM; Reyes-Huerta J; Vivanco-Cid H
Nutrients; 2021 Feb; 13(2):. PubMed ID: 33671228
[TBL] [Abstract][Full Text] [Related]
17. Gut Microbial Dysbiosis in the Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis of Case-Control Studies.
Wang L; Alammar N; Singh R; Nanavati J; Song Y; Chaudhary R; Mullin GE
J Acad Nutr Diet; 2020 Apr; 120(4):565-586. PubMed ID: 31473156
[TBL] [Abstract][Full Text] [Related]
18. Epidemiology of gastroesophageal reflux disease in Iran: a systematic review and meta-analysis.
Karimian M; Nourmohammadi H; Salamati M; Hafezi Ahmadi MR; Kazemi F; Azami M
BMC Gastroenterol; 2020 Sep; 20(1):297. PubMed ID: 32928126
[TBL] [Abstract][Full Text] [Related]
19. Acupoint application therapy for diarrhea-predominant irritable bowel syndrome: a protocol for systematic review and network meta-analysis.
Yin X; Li S; Ouyang M; Ou R; Chen Z; Wei S; Huang H; Liu D
Ann Palliat Med; 2022 Dec; 11(12):3785-3793. PubMed ID: 36510459
[TBL] [Abstract][Full Text] [Related]
20. Irritable Bowel Syndrome and Gluten-Related Disorders.
Usai-Satta P; Bassotti G; Bellini M; Oppia F; Lai M; Cabras F
Nutrients; 2020 Apr; 12(4):. PubMed ID: 32316404
[No Abstract] [Full Text] [Related]
[Next] [New Search]
